Get to know our clinical trials

Efficacy, safety and dose-finding study of XXB750 in patients with resistant hypertension.

THE PURPOSE OF THE STUDY IS TO DETERMINE THE SAFETY OF DIFFERENT DOSES OF XXB750 AND WHAT BENEFIT THEY REPORT COMPARED TO INACTIVE INJECTION IN REDUCING BLOOD PRESSURE IN PATIENTS WITH RESISTANT HYPERTENSION.

Navarre headquarters
Madrid headquarters
Status
In recruitment
headquarters
Pamplona

Technical Summary

  • Code EudraCT: 2021-005738-41
  • Protocol number: CXXB750B12201

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

More information about this clinical trial

Information offered by the Spanish Registry of Clinical Studies

  • Summary
  • Information
  • Calendar
  • Headquarters
  • Drugs
Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial


Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.